Hong Keun-Sik
Department of Neurology, Ilsan Paik Hospital, Inje University, Goyang, Korea.
J Stroke. 2017 May;19(2):152-165. doi: 10.5853/jos.2017.00164. Epub 2017 May 31.
Elevated blood pressure (BP) is the leading modifiable risk factor for stroke and the benefit of BP lowering therapy on the stroke risk reduction is well established. The optimal BP target for preventing stroke and other vascular events have been controversial, but the evidences from epidemiological studies and randomized controlled trials (RCTs) support intensive BP lowering for greater vascular protection, particularly for stroke prevention. For secondary stroke prevention, the evidence of intensive BP lowering benefit is limited since only a single RCT for patients with lacunar infarctions was conducted and most data were driven by exploratory analyses. In acute intracerebral hemorrhage, immediate BP lowering targeting systolic BP<140 mm Hg is recommended by guidelines based on the results from RCTs. In contrast, in acute ischemic stroke, early BP lowering is not usually recommended because of no benefit on functional outcome and future vascular events and potential harm of stroke progression. This review aims to summarize the updated evidence for optimal BP management for primary and secondary stroke prevention and in patients with acute stroke.
血压升高是中风的首要可改变风险因素,降低血压治疗对降低中风风险的益处已得到充分证实。预防中风和其他血管事件的最佳血压目标一直存在争议,但流行病学研究和随机对照试验(RCT)的证据支持强化降压以提供更好的血管保护,特别是预防中风。对于二级中风预防,强化降压益处的证据有限,因为仅针对腔隙性梗死患者进行了一项RCT,且大多数数据由探索性分析得出。在急性脑出血中,基于RCT结果的指南建议将收缩压立即降至<140 mmHg。相比之下,在急性缺血性中风中,通常不建议早期降压,因为对功能结局和未来血管事件无益处,且有中风进展的潜在危害。本综述旨在总结关于一级和二级中风预防以及急性中风患者最佳血压管理的最新证据。